Clinical Trials Browser

ivarmacitinib × Lymphoid × 90 days × Clear all

NCT06519526 2026-03-24

Exploratory Clinical Study of SHR-0302 and SHR-2554 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma

Phase 2 Recruiting

Lymphoma, T-Cell, Peripheral